September 2025 FDA Recall Cyclophosphamide by Sandoz Inc
D-0651-2025 - cGMP deviations

This Class II drug recall was voluntarily initiated by Sandoz Inc on September 5, 2025 for the product Cyclophosphamide. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0651-2025

Reason for Recall
cGMP deviations: Temperature excursion during transportation.
Initiated
09-05-2025
Reported
09-24-2025
Quantity
6 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA
Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multiple Dose Vial, Manufactured in Austria by Fareva Unterach GmbH for Sandoz Inc., Princeton, NJ 08540, Product of India, Vial NDC# 0781-3528-75, Carton NDC# 0781-3528-10.

Batch or Lot Expiration Information

Lot# Only the following 6 GTN Numbers for
Lot# 110459 exp. date 02/28/2027: (01)00307813528104(21)10686040629319 (01)00307813528104(21)10687281435306 (01)00307813528104(21)10687409963168 (01)00307813528104(21)10701200331212 (01)00307813528104(21)10687325644911 (01)00307813528104(21)10687661160169